Fuqiang Ban
2660 Oak Street, V6H 3Z6
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.
Journal: Journal of chemical information and modeling
Published: January 21, 2026
Deep docking, part 2: an amplified DDU platform for ultra-large virtual screening.
Journal: Chemical science
Published: December 08, 2025
Structure-based discovery of inhibitors of Mac1 domain of nonstructural protein-3 of SARS-CoV-2 by machine learning-augmented screening of chemical space.
Journal: bioRxiv : the preprint server for biology
Published: September 18, 2025
Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities.
Journal: Journal of chemical information and modeling
Published: May 26, 2025
Pharmacokinetics, pathology and efficacy of SARS-CoV-2 main protease inhibitor VPC285785 in a murine model of coronavirus infection.
Journal: Scientific reports
Published: May 08, 2025
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein.
Journal: Journal of chemical information and modeling
Published: November 05, 2024
5'-S-(3-Aminophenyl)-5'-thioadenosine, a Novel Chemoprotective Agent for Reducing Toxic Side Effects of Fluorouracil in Treatment of MTAP-Deficient Cancers.
Journal: Molecular cancer therapeutics
Published: August 02, 2024
PROTACable Is an Integrative Computational Pipeline of 3-D Modeling and Deep Learning To Automate the De Novo Design of PROTACs.
Journal: Journal of chemical information and modeling
Published: March 20, 2024
Characterization of novel small molecule inhibitors of estrogen receptor-activation function 2 (ER-AF2).
Journal: Breast cancer research : BCR
Published: March 04, 2024
In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations.
Journal: Chemical science
Published: December 21, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.
Journal: Emerging microbes & infections
Published: August 09, 2023
Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent Inhibitors.
Journal: Journal of chemical information and modeling
Published: March 17, 2023
Last Updated: 09/26/2026